Apr 25, 2014 | Digital Pathology, Instruments & Equipment, Laboratory Management and Operations, Laboratory Operations, Laboratory Pathology
The discovery of dual-purpose condons, called ‘duons’ opens the door to creation of more precise diagnostic and medical laboratory tests, as well as better treatment choices
New insights into the human genome have led to the discovery of a second “code” or “language” within human DNA. Pathologists performing genetic testing will be particularly interested in the implications of this discovery, which the researchers have dubbed “duons.”
It was a research team at the University of Washington (UW) that discovered evidence of a second type of DNA code overlying the protein code that controls transcription factors (TFs). TFs regulate flow of genetic information from DNA to messenger RNA, which manages the synthesis of proteins described by the DNA. (more…)
Dec 14, 2011 | Laboratory Instruments & Laboratory Equipment, Laboratory News, Laboratory Pathology, Management & Operations
Clinical trial demonstrated value of genetic point-of-care testing and a rapid time to result
Here’s a milestone in genetic testing that should catch the attention of pathologists and clinical laboratory managers everywhere. It is a point-of-care (POC) genetic test that is reliable enough to be used in a clinical trial.
The clinical trial was called RAPID GENE. It was conducted at the University of Ottawa Heart Institute (UOHI). The study enrolled 200 patients who were being treated with cardiac stenting for an acute coronary syndrome or stable angina. What made this study unique is that—for the first time in medicine—it used a point-of-care (POC) genetic test. The genetic POCT was used to overcome many previous obstacles that had prevented use of more routine clinical genetic testing.
(more…)